BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 28452619)

  • 1. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
    Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
    J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential utility of FLAIR in MRI-negative Cushing's disease.
    Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
    J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.
    Tabarin A; Laurent F; Catargi B; Olivier-Puel F; Lescene R; Berge J; Galli FS; Drouillard J; Roger P; Guerin J
    Clin Endocrinol (Oxf); 1998 Sep; 49(3):293-300. PubMed ID: 9861318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Dimensional Fast Spin Echo Pituitary MRI in Treatment-Naïve Cushing's Disease: Reduced Impact of Reader Experience and Increased Diagnostic Accuracy.
    Liu Z; Hou B; You H; Lu L; Duan L; Li M; Fan X; Deng K; Yao Y; Zhu H; Feng F
    J Magn Reson Imaging; 2024 Jun; 59(6):2115-2123. PubMed ID: 37656167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas.
    Kasaliwal R; Sankhe SS; Lila AR; Budyal SR; Jagtap VS; Sarathi V; Kakade H; Bandgar T; Menon PS; Shah NS
    Clin Endocrinol (Oxf); 2013 Jun; 78(6):825-30. PubMed ID: 23061773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution contrast-enhanced MRI with three-dimensional fast spin echo improved the diagnostic performance for identifying pituitary microadenomas in Cushing's syndrome.
    Liu Z; Hou B; You H; Lu L; Duan L; Li M; Deng K; Yao Y; Zhu H; Feng F
    Eur Radiol; 2023 Sep; 33(9):5984-5992. PubMed ID: 37212846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
    Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR
    J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of three-Tesla magnetic resonance imaging for the identification of pituitary adenoma in patients with Cushing's disease.
    Fukuhara N; Inoshita N; Yamaguchi-Okada M; Tatsushima K; Takeshita A; Ito J; Takeuchi Y; Yamada S; Nishioka H
    Endocr J; 2019 Mar; 66(3):259-264. PubMed ID: 30760659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary magnetic resonance imaging in Cushing's disease.
    Vitale G; Tortora F; Baldelli R; Cocchiara F; Paragliola RM; Sbardella E; Simeoli C; Caranci F; Pivonello R; Colao A;
    Endocrine; 2017 Mar; 55(3):691-696. PubMed ID: 27435590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary tumour localization in patients with Cushing's disease by magnetic resonance imaging. Is there a place for petrosal sinus sampling?
    de Herder WW; Uitterlinden P; Pieterman H; Tanghe HL; Kwekkeboom DJ; Pols HA; Singh R; van de Berge JH; Lamberts SW
    Clin Endocrinol (Oxf); 1994 Jan; 40(1):87-92. PubMed ID: 8306486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cavernous and inferior petrosal sinus sampling and dynamic magnetic resonance imaging in the preoperative evaluation of Cushing's disease.
    Potts MB; Shah JK; Molinaro AM; Blevins LS; Tyrrell JB; Kunwar S; Dowd CF; Hetts SW; Aghi MK
    J Neurooncol; 2014 Feb; 116(3):593-600. PubMed ID: 24398617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Petrosal sinus sampling for diagnosis of Cushing's disease: evidence of false negative results.
    López J; Barceló B; Lucas T; Salame F; Alameda C; Boronat M; Salto L; Estrada J
    Clin Endocrinol (Oxf); 1996 Aug; 45(2):147-56. PubMed ID: 8881446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for 11C-methionine PET imaging in ACTH-dependent Cushing's syndrome.
    Koulouri O; Steuwe A; Gillett D; Hoole AC; Powlson AS; Donnelly NA; Burnet NG; Antoun NM; Cheow H; Mannion RJ; Pickard JD; Gurnell M
    Eur J Endocrinol; 2015 Oct; 173(4):M107-20. PubMed ID: 26245763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metyrapone pre-treated inferior petrosal sinus sampling in the differential diagnosis of ACTH-dependent Cushing's syndrome.
    Cuneo RC; Lee W; Harper J; Mitchell K; Ward G; Atkinson RL; Salkield I; Cameron DP
    Clin Endocrinol (Oxf); 1997 May; 46(5):607-18. PubMed ID: 9231057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does pituitary compression/empty sella syndrome contribute to MRI-negative Cushing's disease? A single-institution experience.
    Himes BT; Bhargav AG; Brown DA; Kaufmann TJ; Bancos I; Van Gompel JJ
    Neurosurg Focus; 2020 Jun; 48(6):E3. PubMed ID: 32480375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different imaging characteristics of concurrent pituitary adenomas in a patient with Cushing's disease.
    Mehta GU; Montgomery BK; Raghavan P; Sharma S; Nieman LK; Patronas N; Oldfield EH; Chittiboina P
    J Clin Neurosci; 2015 May; 22(5):891-4. PubMed ID: 25827866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cavernous sinus sampling in patients with Cushing's disease.
    Burkhardt T; Flitsch J; van Leyen P; Sauer N; Aberle J; Grzyska U; Lüdecke DK
    Neurosurg Focus; 2015 Feb; 38(2):E6. PubMed ID: 25639324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of spoiled-gradient echo 3D-T1 sequence in deciding appropriate treatment strategy for ACTH-producing pituitary adenoma; a case report and review of the literature.
    Kunihiro J; Inoue A; Miyake T; Nakaguchi H; Kitazawa R; Kunieda T
    Int J Surg Case Rep; 2023 May; 106():108242. PubMed ID: 37087938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China.
    Zhang K; Shen M; Qiao N; Chen Z; He W; Ma Z; Shou X; Li S; Zhao Y; Pan L; Liu D; He M; Zhang Z; Li Y; Yao Z; Ye H; Wang Y
    Neurosurg Focus; 2020 Jun; 48(6):E7. PubMed ID: 32480378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.
    Carr SB; Kleinschmidt-DeMasters BK; Kerr JM; Kiseljak-Vassiliades K; Wierman ME; Lillehei KO
    J Neurosurg; 2018 Nov; 129(5):1260-1267. PubMed ID: 29219752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.